 EDINBURGH, United Kingdom, Aug. 19, 2021 GLOBE NEWSWIRE -- NuCana plc NASDAQ: NCNA announced financial results for the second quarter ended June 30, 2021 and provided an update on its broad clinical program with its transformative ProTide therapeutics. 